WO2017216677A1 - Single use pharmaceutical composition for rectal administration - Google Patents
Single use pharmaceutical composition for rectal administration Download PDFInfo
- Publication number
- WO2017216677A1 WO2017216677A1 PCT/IB2017/053318 IB2017053318W WO2017216677A1 WO 2017216677 A1 WO2017216677 A1 WO 2017216677A1 IB 2017053318 W IB2017053318 W IB 2017053318W WO 2017216677 A1 WO2017216677 A1 WO 2017216677A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ginger
- nausea
- form according
- vomiting
- grams
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 12
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 12
- 239000011709 vitamin E Substances 0.000 claims abstract description 12
- 229940046009 vitamin E Drugs 0.000 claims abstract description 12
- 244000098338 Triticum aestivum Species 0.000 claims abstract description 9
- 235000020708 ginger extract Nutrition 0.000 claims abstract description 9
- 229940002508 ginger extract Drugs 0.000 claims abstract description 7
- 239000006286 aqueous extract Substances 0.000 claims abstract description 6
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims abstract description 3
- 210000004877 mucosa Anatomy 0.000 claims description 14
- 239000000829 suppository Substances 0.000 claims description 9
- 208000024891 symptom Diseases 0.000 claims description 7
- 230000007794 irritation Effects 0.000 claims description 2
- 241000234314 Zingiber Species 0.000 description 29
- 235000006886 Zingiber officinale Nutrition 0.000 description 29
- 235000008397 ginger Nutrition 0.000 description 29
- 206010047700 Vomiting Diseases 0.000 description 18
- 230000000694 effects Effects 0.000 description 12
- 241000209140 Triticum Species 0.000 description 11
- 235000021307 Triticum Nutrition 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 6
- 206010028813 Nausea Diseases 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 230000008693 nausea Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- 230000035935 pregnancy Effects 0.000 description 5
- 230000001681 protective effect Effects 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- 235000013339 cereals Nutrition 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000013059 nephrectomy Methods 0.000 description 4
- 239000000902 placebo Substances 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 238000002512 chemotherapy Methods 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 230000030135 gastric motility Effects 0.000 description 3
- 235000002780 gingerol Nutrition 0.000 description 3
- 230000000622 irritating effect Effects 0.000 description 3
- 229940068196 placebo Drugs 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- 229920000715 Mucilage Polymers 0.000 description 2
- 206010028817 Nausea and vomiting symptoms Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 235000013334 alcoholic beverage Nutrition 0.000 description 2
- 239000002111 antiemetic agent Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 229960001253 domperidone Drugs 0.000 description 2
- FGXWKSZFVQUSTL-UHFFFAOYSA-N domperidone Chemical compound C12=CC=CC=C2NC(=O)N1CCCN(CC1)CCC1N1C2=CC=C(Cl)C=C2NC1=O FGXWKSZFVQUSTL-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 239000002895 emetic Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 235000019149 tocopherols Nutrition 0.000 description 2
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 2
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 2
- BGRJTUBHPOOWDU-NSHDSACASA-N (S)-(-)-sulpiride Chemical compound CCN1CCC[C@H]1CNC(=O)C1=CC(S(N)(=O)=O)=CC=C1OC BGRJTUBHPOOWDU-NSHDSACASA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000269350 Anura Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 206010017918 Gastroenteritis viral Diseases 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 206010022678 Intestinal infections Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 208000031649 Postoperative Nausea and Vomiting Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010049418 Sudden Cardiac Death Diseases 0.000 description 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 1
- 102000002852 Vasopressins Human genes 0.000 description 1
- 108010004977 Vasopressins Proteins 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001705 anti-serotonergic effect Effects 0.000 description 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 238000010523 cascade reaction Methods 0.000 description 1
- NCEXYHBECQHGNR-UHFFFAOYSA-N chembl421 Chemical compound C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 1
- 150000005829 chemical entities Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000741 diarrhetic effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000586 effect on nausea Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000002344 fibroplastic effect Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960004145 levosulpiride Drugs 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000020793 low-cost food Nutrition 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 238000010197 meta-analysis Methods 0.000 description 1
- 229960004503 metoclopramide Drugs 0.000 description 1
- TTWJBBZEZQICBI-UHFFFAOYSA-N metoclopramide Chemical compound CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC TTWJBBZEZQICBI-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 238000009394 selective breeding Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000001515 vagal effect Effects 0.000 description 1
- 239000006216 vaginal suppository Substances 0.000 description 1
- 229960003726 vasopressin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 1
- 229930001895 zingiberene Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
Definitions
- the present invention relates to a single use (disposable) pharmaceutical composition form for rectal administration.
- the object of this invention is to be conveniently and effectively used in the field of medical devices, in particular as for the treatment of symptoms related to irritative states of the ano-rectal mucosa, such as irritation, itching and burning caused by the high number of daily diarrheal discharges due to viral gastroenteritis or intestinal infections characterized by aqueous diarrhoea, abdominal cramps, nausea, vomiting.
- Another object of the present invention is to develop a pharmaceutical form, e.g.
- a suppository or a gel, a ointment, a cream or the like, in its version for adults or, alternatively, for use in the paediatric field, which might be able to effectively help restore the integrity and the physiological functionality of the ano-rectal mucosa and reduce the symptoms related to the irritative processes of the ano-rectal mucosa itself.
- this single use disposable pharmaceutical composition form is a suppository for rectal use having the following composition:
- Triticum vulgare (or Triticum aestivum) is soft wheat, or wheat, the know plant belonging to the Gramineae family, being cultivated for over 10,000 years. This is clearly a very widespread plant species, which is also equally studied, mainly for its food applications (its flour is the most suitable one for bread-making and it is used instead of all other flours that were used for this purpose in many countries of the world). What is also clear is that the grown varieties stem from a long artificial selection, which still continues, aimed at improving its resistance, yield, cultivation ease, ripening speed and all those features that may be useful for its cultivation and use. In particular, this pharmaceutical form is the aqueous extract obtained from the so called "wheat germ", which is incorporated as the active ingredient.
- the term "Wheat germ” refers to a special portion of the caryopsis (the grain) of wheat, which amounts to just a narrow percentage by weight of the entire grain and which represents its sprouting part (from which the plant grows).
- the wheat germ can be mechanically separated from its grain and it has been marketed for direct food consumption for a long time.
- the wheat germ contains many different substances (fat, vitamins, minerals), which make it an interesting ingredient thanks to its nutritional properties. D Thanks to its special composition, characterized by the presence of starches, phospholipids and glycolipids, the wheat germ extract plays its role within this DM.
- the wheat germ extract is also used in moisturising dermatological products and as a skin protective and conditioning ingredient.
- This ingredient is, in fact, included in the European database of cosmetic ingredients (COSING) and can be used without limitations for those products intended for cosmetic use.
- Tocopherols are a class of organic compounds having, in general, the same activities as vitamin E; this is the reason why the definition of vitamin E does not refer to just one chemical entity.
- the product dl-a-Tocopheryl Acetate which is commercially one of the most widely used products due to various reasons related to its stability, has been added.
- tocopherols are fat-soluble alcohols having a strong antioxidant activity, even if they also perform many other physiological functions in the body. DTheir antioxidant activity counteracts radical oxidation phenomena, and has an inhibitory action against free radicals. Vitamin E is able to stop the radical cascade reaction by giving a hydrogen atom to the reactive radicals, and turning into an inert radical.
- Vitamin E plays an important role, as an antioxidant factor, in the prevention of the oxidation of polyunsaturated fatty acids, which is the key event in the development of the lipid peroxidation process.
- the industrial sector (in addition to its obvious use as a food supplement) uses vitamin E as a low cost food preservative, characterized by a high safety level.
- Vitamin E also plays an important role as an ingredient for cosmetic preparations, in which (in addition to acting as a preservative) it also protects the skin and mucosa against any damage caused by free radicals and oxidative stress factors (exposure to UV, pollution, etc.).
- this ingredient is used as a preservative, thus preserving this form from oxidative stress, both inside its final container and after the product has been used.
- Ginger is a herbaceous plant belonging to the Zingiberaceae family (the same family as cardamom) stemming from the far east. Ginger is cultivated in the entire tropical and subtropical belts. It is characterized by a fleshy and densely branched rhizome, out of which both long hollow and sterile trunks - formed by lanceolate sheathing leaves - and short fertile flower stalks grow, and bear yellow- greenish flowers with crimson stains. Its fruit is a capsule subdivided into three locules by septa.
- the rhizome is the used part of the plant and which contains the active ingredients: essential oil (mainly composed by zingiberene), gingerols and shogaols (which cause its sharp taste), resins and mucilage, and is characterized by the typical taste and aroma thanks to which ginger is widely used as a spice, in its dried or pulverized form, or fresh as thin slices. It is also used to prepare alcoholic drinks and beverages. Although mainly intended for food use, it is also well known as a medicinal plant, mainly as an antiemetic, but also as an anti-inflammatory agent. However, these functions are not relevant to this medical preparation (since it is not intended for oral administration).
- ginger helps develop the film- forming and protective effect of the wheat germ extract, therefore supporting its action. In addition to this, and also thanks to this film-forming effect, it has a soothing effect on the irritated mucosa, thus alleviating the pain.
- the European legislation regulates its use in cosmetic products (without safety restrictions) as a skin conditioning agent. Ginger is very effective against nausea, and according to some clinical studies, this may be due to its activity of antiserotoninergic type, stopping the transmission of the 5-HT3 emetic signal.
- 5-HT3 gastric receptors are important for the onset of vomiting. Experimental evidence suggests that some ginger components are able to stop this receptor, thus reducing the emetic signal reaching the central system (through the vagal connections) and increasing the gastric motility (the block of 5-HT3 gastro-intestinal receptors implies an increase of acetylcholine release, a neurotransmitter that stimulates the gastro-intestinal motility).
- gingerols 33%
- shogaols zingerone
- Gingerols especially the 6-gingerol, and shogaols, are the active ingredients responsible for its biological activity, since these elements are capable of inhibiting vomiting induced by copper sulphate in frogs.
- a study involving healthy volunteers showed that nausea induced by circular movement was inhibited by therapeutic doses of ginger.
- ginger The effectiveness of ginger for treating nausea depends on the condition causing it; as a matter of fact, it has been observed that ginger can counteract nausea and vomiting arising during pregnancy.
- ginger is safe if used during pregnancy, since there are no significant differences with respect to placebos, as for side effects or adverse reactions during pregnancy and it does not entail any significant risk of causing possible side effects, such as heartburn or drowsiness.
- ginger could be considered as an effective and harmless alternative for women suffering from nausea and vomiting during pregnancy (Estelle Viljoen, Janicke Visser, Nelene Koen and Alfred Musekiwa; Viljoen et al.; A systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy- associated nausea and vomiting; Nutrition Journal 2014, 13:20).
- Ginger has proved to be effective even when nausea and vomiting are caused by chemotherapy (Inaki Lete and Jose Allue; The Effectiveness of Ginger in the Prevention of Nausea and Vomiting during Pregnancy and Chemotherapy; Libertas academica; Integrative Medicine Insights 2016:1 1 ).
- Ginger is effective in diminishing post-surgery nausea and vomiting symptoms both in individuals that underwent open nephrectomy, and in individuals that underwent laparoscopic nephrectomy. Ginger may thus be recommended as a complementary remedy to prevent and treat post-op nausea and vomiting in patients that underwent nephrectomy.
- ginger may also be a reasonable and safe alternative for the treatment of nausea and vomiting in pregnant women and that it may be useful for the treatment of nausea and vomiting symptoms induced by chemotherapy.
- the prokinetic effects affecting gastric motility may suggest a potential role of ginger extracts in treating various digestive diseases and in particular functional dyspepsia, as well as those patients who suffer from neurological or endocrinological side effects due to the use of prokinetic drugs, such as domperidone, levosulpiride or metoclopramide.
- the treatment based on ginger extracts might avoid the risk of sudden cardiac death, observed in elderly patients treated with domperidone doses higher than 30 mg for 31 -34 days. Further studies are needed to be able to confirm such hypothesis and other interesting properties that are worth studying. (A. GIACOSA, P. MORAZZONI, et.al; Can nausea and vomiting be treated with ginger extract?; European Review for Medical and Pharmacological Sciences; 2015; 19: 1291 -1296). Suppocire BS2X, or other triglyceride equivalent excipient.
- This pharmaceutical form is mono-, bi- and triglycerides of saturated fatty acids (the preferred, but not limiting, mixture is sold with the following trade name: SUPPOCIRE BS2X).
- SUPPOCIRE BS2X the preferred, but not limiting, mixture is sold with the following trade name: SUPPOCIRE BS2X.
- This product is specifically manufactured to be the vehicle for suppositories and vaginal suppositories: it is solid at room temperature and melts after being inserted because of the body temperature. This is a standard ingredient, prepared according to the rules of good manufacturing of pharmaceutical excipients.
- the pharmaceutical suppository form melts at body temperature after being inserted and the semi-synthetic triglycerides, constituting the vehicle of the formulation, release the substances contained in the form upon contact with the rectal mucosa: ⁇ -
- the Triticum aqueous extract characterized by film-forming properties, lays on the rectal mucosa and has a moisturising and protective effect against irritating stimuli, especially where the mucosa is already irritated, thus helping diminishing the symptoms affecting the irritated mucosa, such as itching and burning.
- the protective film allows to keep the needed humidity conditions in the treated area for a proper healing of the mucosa itself;
- the fat-soluble ginger extract exerts a lenitive action and is effective against nausea and vomiting;
- Vitamin E essentially preserves the formulation thanks to the anti-oxidizing action, which is needed to maintain the features of the semi-synthetic triglycerides.
- the above described pharmaceutical form is, preferably but not limited to, marketed as adult suppositories, 2.0 grams each packed in a blister containing 20
- suppositories and, as children suppositories, 1 .0 grams each packed in a blister containing 10 suppositories.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Single use pharmaceutical composition form suitable for rectal administration, containing the following components: aqueous extract of Triticum Vulgare, and fat-soluble ginger extract, vitamin E, and triglyceride excipient or equivalent.
Description
SINGLE USE PHARMACEUTICAL COMPOSITION FOR RECTAL ADMINISTRATION.
Applicant: SPACE INTERNATIONAL S.A.S., Via Martiri di Via Fani, 2 - 71122 Foggia (FG).
Designated inventors: Celestino Ricciardi and Giovanna Adelizzi
The present invention relates to a single use (disposable) pharmaceutical composition form for rectal administration.
The object of this invention is to be conveniently and effectively used in the field of medical devices, in particular as for the treatment of symptoms related to irritative states of the ano-rectal mucosa, such as irritation, itching and burning caused by the high number of daily diarrheal discharges due to viral gastroenteritis or intestinal infections characterized by aqueous diarrhoea, abdominal cramps, nausea, vomiting. Another object of the present invention is to develop a pharmaceutical form, e.g. a suppository, or a gel, a ointment, a cream or the like, in its version for adults or, alternatively, for use in the paediatric field, which might be able to effectively help restore the integrity and the physiological functionality of the ano-rectal mucosa and reduce the symptoms related to the irritative processes of the ano-rectal mucosa itself. The structural and functional characteristics of the present invention and its advantages with respect to pharmaceutical forms of the known art that are now available on the market, will be clearer and more evident from the claims below and, in particular, from an examination of the following detailed description.
According to a preferred, but not limiting, structural embodiment, this single use disposable pharmaceutical composition form is a suppository for rectal use having the following composition:
Component details.
Triticum Vulgare (Soft wheat)
Triticum vulgare (or Triticum aestivum) is soft wheat, or wheat, the know plant belonging to the Gramineae family, being cultivated for over 10,000 years. This is clearly a very widespread plant species, which is also equally studied, mainly for its food applications (its flour is the most suitable one for bread-making and it is used instead of all other flours that were used for this purpose in many countries of the world). What is also clear is that the grown varieties stem from a long artificial selection, which still continues, aimed at improving its resistance, yield, cultivation ease, ripening speed and all those features that may be useful for its cultivation and use. In particular, this pharmaceutical form is the aqueous extract obtained from the so called "wheat germ", which is incorporated as the active ingredient. The term "Wheat germ" refers to a special portion of the
caryopsis (the grain) of wheat, which amounts to just a narrow percentage by weight of the entire grain and which represents its sprouting part (from which the plant grows). The wheat germ can be mechanically separated from its grain and it has been marketed for direct food consumption for a long time. Unlike the endosperm (the main element of the grain, which is mainly made of starch and proteins), the wheat germ contains many different substances (fat, vitamins, minerals), which make it an interesting ingredient thanks to its nutritional properties. DThanks to its special composition, characterized by the presence of starches, phospholipids and glycolipids, the wheat germ extract plays its role within this DM. As a matter of fact, it is able to create a film on the surface of the skin or mucosa, which is useful to prevent the loss of liquids, thereby facilitating the return of fibroplastic cells intended for synthesizing the collagen fibres and responsible for the healing process. Since the proteins contained in the wheat germ extract are able to create a moisturising, soothing and skin-protecting colloidal type protective film, the wheat germ extract is also used in moisturising dermatological products and as a skin protective and conditioning ingredient. This ingredient is, in fact, included in the European database of cosmetic ingredients (COSING) and can be used without limitations for those products intended for cosmetic use.
Vitamin E.
Tocopherols are a class of organic compounds having, in general, the same activities as vitamin E; this is the reason why the definition of vitamin E does not refer to just one chemical entity. In this DM, the product dl-a-Tocopheryl Acetate, which is commercially one of the most widely used products due to various reasons related to its stability, has been added. In terms of reactivity, tocopherols are fat-soluble alcohols having a strong antioxidant activity, even if they also perform many other physiological
functions in the body. DTheir antioxidant activity counteracts radical oxidation phenomena, and has an inhibitory action against free radicals. Vitamin E is able to stop the radical cascade reaction by giving a hydrogen atom to the reactive radicals, and turning into an inert radical. Vitamin E plays an important role, as an antioxidant factor, in the prevention of the oxidation of polyunsaturated fatty acids, which is the key event in the development of the lipid peroxidation process. The industrial sector (in addition to its obvious use as a food supplement) uses vitamin E as a low cost food preservative, characterized by a high safety level.□ Vitamin E also plays an important role as an ingredient for cosmetic preparations, in which (in addition to acting as a preservative) it also protects the skin and mucosa against any damage caused by free radicals and oxidative stress factors (exposure to UV, pollution, etc.). This is the reason why it is widely used in many topical products, such as creams, sera, anti-age gels, antioxidants and brightening products, as well as preparations for vaginal or anorectal use. In this form, this ingredient is used as a preservative, thus preserving this form from oxidative stress, both inside its final container and after the product has been used.
Ginger extract.
Ginger (Zingiber officinalis) is a herbaceous plant belonging to the Zingiberaceae family (the same family as cardamom) stemming from the far east. Ginger is cultivated in the entire tropical and subtropical belts. It is characterized by a fleshy and densely branched rhizome, out of which both long hollow and sterile trunks - formed by lanceolate sheathing leaves - and short fertile flower stalks grow, and bear yellow- greenish flowers with crimson stains. Its fruit is a capsule subdivided into three locules by septa. The rhizome is the used part of the plant and which contains the active ingredients: essential oil (mainly composed by zingiberene), gingerols and shogaols
(which cause its sharp taste), resins and mucilage, and is characterized by the typical taste and aroma thanks to which ginger is widely used as a spice, in its dried or pulverized form, or fresh as thin slices. It is also used to prepare alcoholic drinks and beverages. Although mainly intended for food use, it is also well known as a medicinal plant, mainly as an antiemetic, but also as an anti-inflammatory agent. However, these functions are not relevant to this medical preparation (since it is not intended for oral administration). Thanks to the presence of mucilage, ginger helps develop the film- forming and protective effect of the wheat germ extract, therefore supporting its action. In addition to this, and also thanks to this film-forming effect, it has a soothing effect on the irritated mucosa, thus alleviating the pain. The European legislation regulates its use in cosmetic products (without safety restrictions) as a skin conditioning agent. Ginger is very effective against nausea, and according to some clinical studies, this may be due to its activity of antiserotoninergic type, stopping the transmission of the 5-HT3 emetic signal.
5-HT3 gastric receptors are important for the onset of vomiting. Experimental evidence suggests that some ginger components are able to stop this receptor, thus reducing the emetic signal reaching the central system (through the vagal connections) and increasing the gastric motility (the block of 5-HT3 gastro-intestinal receptors implies an increase of acetylcholine release, a neurotransmitter that stimulates the gastro-intestinal motility).
The main elements constituting ginger are: gingerols (33%), shogaols, zingerone. Gingerols, especially the 6-gingerol, and shogaols, are the active ingredients responsible for its biological activity, since these elements are capable of inhibiting vomiting induced by copper sulphate in frogs. A study involving healthy volunteers showed that nausea induced by circular movement was inhibited by therapeutic doses
of ginger. These beneficial effects were associated with a normalization of the gastric motility and inhibition of the vasopressin release (Lien and coll. 2003).
The effectiveness of ginger for treating nausea depends on the condition causing it; as a matter of fact, it has been observed that ginger can counteract nausea and vomiting arising during pregnancy. A study carried out on 187 pregnant women showed that ginger does not increase the risk of malformations (Portnoi and coll. -
2003).
More studies on ginger have further highlighted its ability to reduce the symptoms of nausea and vomiting in pregnant women, thus becoming an alternative choice to conventional medical products that may have possible harmful side effects. Orally administered ginger significantly improved those symptoms related to nausea if compared to the placebo administered to the control group (MD 1 .20, 95% CI 0.56- 1 .84, p = 0.0002, I2 = 0%) and, even if it did not reduce significantly the number of episodes of vomiting compared to placebo, it showed a trend towards improvement. Research also shows that ginger is safe if used during pregnancy, since there are no significant differences with respect to placebos, as for side effects or adverse reactions during pregnancy and it does not entail any significant risk of causing possible side effects, such as heartburn or drowsiness. On the basis of the evidence of this study, ginger could be considered as an effective and harmless alternative for women suffering from nausea and vomiting during pregnancy (Estelle Viljoen, Janicke Visser, Nelene Koen and Alfred Musekiwa; Viljoen et al.; A systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy- associated nausea and vomiting; Nutrition Journal 2014, 13:20).
Ginger has proved to be effective even when nausea and vomiting are caused by chemotherapy (Inaki Lete and Jose Allue; The Effectiveness of Ginger in the
Prevention of Nausea and Vomiting during Pregnancy and Chemotherapy; Libertas academica; Integrative Medicine Insights 2016:1 1 ).
Another study proposed the assessment of the effectiveness of ginger on the intensity of nausea and vomiting as post-operative side effects after surgery. 160 patients were divided into two groups: one was treated with control placebo and the other one was treated with ginger; the two groups were given 4 capsules of product one hour before surgery and the effects of this administration on nausea and vomiting were assessed 2, 4 and 6 hours after surgery. The intensity of vomiting and nausea was significantly lower in those groups treated with ginger at all times considered by the study. Ginger could then be safely used as an antiemetic drug after surgery. (Akram Sadat Montazeri, Azam Hamidzadeh e coll.; Evaluation of Oral Ginger Efficacy against Postoperative Nausea and Vomiting A Randomized Double - Blinded Clinical Trial; Iran Red Crescent Med J. 2013 December; 15(12): e12268.)
Ginger is effective in diminishing post-surgery nausea and vomiting symptoms both in individuals that underwent open nephrectomy, and in individuals that underwent laparoscopic nephrectomy. Ginger may thus be recommended as a complementary remedy to prevent and treat post-op nausea and vomiting in patients that underwent nephrectomy. (Fatemeh Sadat Hosseini; Mohsen Adib-Hajbaghery; Ginger Essence Effect on Nausea and Vomiting After Open and Laparoscopic Nephrectomies; Nurs Midwifery Stud. 2015 June; 4(2): e28625);
Studies were also performed to assess ginger effectiveness on arthritis; however, for these studies to be significant, they should be further developed (BRETT WHITE; Ginger: An Overview; American Family Physician; Volume 75, Number 1 1 ; June 1 , 2007)
Other studies show that ginger may also be a reasonable and safe alternative for the
treatment of nausea and vomiting in pregnant women and that it may be useful for the treatment of nausea and vomiting symptoms induced by chemotherapy. The prokinetic effects affecting gastric motility may suggest a potential role of ginger extracts in treating various digestive diseases and in particular functional dyspepsia, as well as those patients who suffer from neurological or endocrinological side effects due to the use of prokinetic drugs, such as domperidone, levosulpiride or metoclopramide.
In particular, the treatment based on ginger extracts might avoid the risk of sudden cardiac death, observed in elderly patients treated with domperidone doses higher than 30 mg for 31 -34 days. Further studies are needed to be able to confirm such hypothesis and other interesting properties that are worth studying. (A. GIACOSA, P. MORAZZONI, et.al; Can nausea and vomiting be treated with ginger extract?; European Review for Medical and Pharmacological Sciences; 2015; 19: 1291 -1296). Suppocire BS2X, or other triglyceride equivalent excipient.
Other components of this pharmaceutical form are mono-, bi- and triglycerides of saturated fatty acids (the preferred, but not limiting, mixture is sold with the following trade name: SUPPOCIRE BS2X). This product is specifically manufactured to be the vehicle for suppositories and vaginal suppositories: it is solid at room temperature and melts after being inserted because of the body temperature. This is a standard ingredient, prepared according to the rules of good manufacturing of pharmaceutical excipients.
Mechanism of action.
The pharmaceutical suppository form melts at body temperature after being inserted and the semi-synthetic triglycerides, constituting the vehicle of the formulation, release the substances contained in the form upon contact with the rectal mucosa:□
- The Triticum aqueous extract, characterized by film-forming properties, lays on the rectal mucosa and has a moisturising and protective effect against irritating stimuli, especially where the mucosa is already irritated, thus helping diminishing the symptoms affecting the irritated mucosa, such as itching and burning. The protective film allows to keep the needed humidity conditions in the treated area for a proper healing of the mucosa itself;
- The fat-soluble ginger extract exerts a lenitive action and is effective against nausea and vomiting;
Vitamin E essentially preserves the formulation thanks to the anti-oxidizing action, which is needed to maintain the features of the semi-synthetic triglycerides.□
Therefore, functional substances - through the above described mechanisms of action - help restore the integrity and the physiological functions of the ano-rectal mucosa and reduce the symptoms related to the inflammatory process of the mucosa itself. DThe remaining components are common excipients that are used in forms for rectal use in the pharmaceutical field.□
The above described pharmaceutical form is, preferably but not limited to, marketed as adult suppositories, 2.0 grams each packed in a blister containing 20
suppositories and, as children suppositories, 1 .0 grams each packed in a blister containing 10 suppositories.
Claims
1. Single use pharmaceutical form suitable for rectal administration, containing the following components: aqueous extract of Triticum Vulgare, fat-soluble ginger extract, Vitamin E, and an excipient triglyceride or equivalent.
2. Form according to claim 1 , containing a percentage up to 10 grams of said aqueous extract of Triticum Vulgare.
3. Form according to claim 2, wherein said aqueous extract of Triticum Vulgare is equal to 0.005 grams.
4. Form according to one or more of claims 1 to 3, containing a percentage up to 10 grams of said soluble ginger extract.
5. Form according to claim 4, wherein said soluble ginger extract is equal to 0,300 grams.
6. Form according to one or more of claims 1 to 5, containing a percentage up to 10 grams of said vitamin E.
7. Form according to claim 6, wherein said Vitamin E is equal to 0.005 grams.
8. Suppository comprising the pharmaceutical form according to one or more of the preceding claims 1 to 7.
9. Use of the pharmaceutical form according to one or more of the preceding claims 1 to 7 or 8, in the treatment of symptoms of irritation of the anorectal mucosa.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17733895.1A EP3471700A1 (en) | 2016-06-17 | 2017-06-06 | Single use pharmaceutical composition for rectal administration |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITUA2016A004447 | 2016-06-17 | ||
ITUA2016A004447A ITUA20164447A1 (en) | 2016-06-17 | 2016-06-17 | PHARMACEUTICAL FORM DISPOSABLE FOR RECTAL USE. |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2017216677A1 true WO2017216677A1 (en) | 2017-12-21 |
Family
ID=57184696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2017/053318 WO2017216677A1 (en) | 2016-06-17 | 2017-06-06 | Single use pharmaceutical composition for rectal administration |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3471700A1 (en) |
IT (1) | ITUA20164447A1 (en) |
WO (1) | WO2017216677A1 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101339706B1 (en) * | 2013-06-20 | 2013-12-10 | 재단법인 금산국제인삼약초연구소 | A compound for immune strengthen inclusion reducing the bitterness of red ginseng, the extract of immune, and the probiotics |
-
2016
- 2016-06-17 IT ITUA2016A004447A patent/ITUA20164447A1/en unknown
-
2017
- 2017-06-06 EP EP17733895.1A patent/EP3471700A1/en not_active Withdrawn
- 2017-06-06 WO PCT/IB2017/053318 patent/WO2017216677A1/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101339706B1 (en) * | 2013-06-20 | 2013-12-10 | 재단법인 금산국제인삼약초연구소 | A compound for immune strengthen inclusion reducing the bitterness of red ginseng, the extract of immune, and the probiotics |
Also Published As
Publication number | Publication date |
---|---|
ITUA20164447A1 (en) | 2017-12-17 |
EP3471700A1 (en) | 2019-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Singh et al. | Phytochemistry, traditional uses and cancer chemopreventive activity of Amla (Phyllanthus emblica): The Sustainer | |
Krishna et al. | Review on nutritional, medicinal and pharmacological properties of Papaya (Carica papaya Linn.) | |
Gerometta et al. | A review of traditional uses, phytochemistry and pharmacology of the genus Indigofera | |
Bartram | Bartram's encyclopedia of herbal medicine | |
Priya et al. | Phyllanthus emblica Linn.(Amla)—a natural gift to humans: an overview | |
US20190008907A1 (en) | Compositions for management of wounds, skin diseases, dehydration, chronic diseases, and respiratory diseases | |
CN110478477A (en) | A kind of traditional Chinese biological preparation and preparation method thereof promoting female reproductive health | |
Yampolsky et al. | Sea buckthorn (lat. Hippophaë) | |
Dharani et al. | An Illustrated Guide to Medicinal Plants of East Africa | |
JP2008520659A (en) | Anti-inflammatory extract and drug and method for producing the same | |
Boon et al. | The complete natural medicine guide to the 50 most common medicinal herbs | |
Loría Gutiérrez et al. | General aspects about Allium sativum-a review | |
Brendler et al. | Devil’s Claw (Harpagophytum procumbens DC) an evidence-based systematic review by the natural standard research collaboration | |
Shivangini et al. | Comprehensive Review: Miracle Tree Moringa oleifera Lam. | |
Sharma et al. | An overview on Calendula officinalis Linn.:(pot marigold) | |
Aleem et al. | Therapeutic potential of Habb-ul-Aas (Myrtus communis Linn.) with unani perspective and modern pharmacology: A review | |
KR20200118322A (en) | Cleanser for women and methods for manufacturing the same | |
EP3471700A1 (en) | Single use pharmaceutical composition for rectal administration | |
Prajapati et al. | Opuntia elatior Mill.(Nagaphani): A review on its ethnobotany, phytochemical and pharmacological properties | |
KR101846528B1 (en) | Composition for preventing hair loss and promoting a growth hair | |
KR20110121295A (en) | Composition of external skin preparation for alleviation of menstrual cramp | |
Panda | Aloe vera handbook cultivation, research finding, products, formulations, extraction & processing | |
Shukla | Neem Benefits, Uses and Side Effects | |
Viquar | Detoxification of the Therapeutically Essential Drug Aelwa (Aloe vera (L.) Burm. f.) Using a Modified Traditional Method | |
Parvizi et al. | Olive in traditional Persian medicine: an overview |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17733895 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2017733895 Country of ref document: EP Effective date: 20190117 |